🛡️ Public data only — no PHI permitted on this instance.

HOSP

BETH ISRAEL DEACONESS - PLYMOUTH

CCN 220060|LOC PLYMOUTH, MA|BEDS 150|NPR $349.1M|MARGIN 2.6%

SeekingChartis Score

INVESTMENT THESIS

Buy: BETH ISRAEL DEACONESS - PLYMOUTH

/ 100 (B)

+$25.7M

EBITDA Uplift

+736bps

Margin Δ

0.0%

Op Margin

$349.1M

Revenue

—

Realization

—

Peer Rank

SIGNAL STRENGTH

Margin

0.0%

Safety

60%

CATALYSTS

▲RCM uplift of $25.7M (+736bps)

RISKS

▼Elevated distress risk (40%)

Buy — solid fundamentals with identifiable value creation levers. Proceed to detailed diligence.

Peer Analysis EBITDA Bridge Data Room IC Memo ML Detail

$349.1M

Net Patient Revenue

2.6%

Operating Margin

$8.9M

Net Income

150

Licensed Beds

$2,327K

Revenue per Bed

$340.2M

Operating Expenses

Payer Mix

PYR

■ MEDICARE · 47%■ MEDICAID · 7%■ COMMERCIAL · 46%

Score Breakdown

SCComposite · 39/100

Component	Score	Max	%
Market Position	17	35	49%
Financial Health	11	25	44%
Operational Quality	0	20	0%
Competitive Moat	3	20	15%

Comparable Hospitals

CMP

CCN	Hospital	Beds	NPR
220001	HEALTHALLIANCE-CLINTON	125	$0M
220002	MOUNT AUBURN HOSPITAL	186	$0M
220008	STURDY MEMORIAL HOSPITAL	125	$0M
220010	LAWRENCE GENERAL HOSPITAL	186	$0M
220011	CAMBRIDGE HEALTH ALLIANCE	225	$0M

Team Notes

NOTE0 entries

Actions

ACT

WFDiligence Workflow

Competitive Intel EBITDA Bridge Data Room IC Memo Scenarios

AIDeep Analysis

ML Analysis Demand 3-Year History Stats Bayesian

FINFinancial Models

DCF LBO 3-Statement Returns Market Denial

MORE IN MAStart Diligence · creates a deal from HCRIS